Desvenlafaxine Extended-Release Tablets Suppliers & Bulk Manufacturers

Available Forms: Extended-Release Tablets

Available Strengths: 25 mg, 50 mg, 100 mg

Reference Brands: Pristiq®(US & EU), Khedezla®(US)

Category: Antipsychotropic Drugs

Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that enhances neurotransmitter levels to help regulate mood and emotional balance. It is primarily used for the treatment of major depressive disorder (MDD) in adults. The extended-release formulation ensures once-daily dosing, providing consistent therapeutic effects with improved adherence and reduced dosing frequency. Desvenlafaxine Extended-Release Tablets is available in Extended-Release Tablets and strengths such as 25 mg, 50 mg, 100 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Desvenlafaxine Extended-Release Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Desvenlafaxine Extended-Release Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: In the United States, desvenlafaxine extended-release tablets are FDA-approved for the treatment of major depressive disorder (MDD) in adults. As an SNRI, it requires a Boxed Warning regarding the risk of suicidal thoughts and behaviors in young individuals. Regulatory compliance includes GMP manufacturing, bioequivalence studies for generics, and ongoing post-marketing surveillance. Labeling must reflect FDA-approved indications, dosing, and adverse effects. In the European Union, desvenlafaxine is not widely marketed, but regulatory pathways exist for national or decentralized approval. Applications must include clinical efficacy, pharmacovigilance plans, and Risk Management Plans (RMPs). For compliant global sourcing, visit Pharmatradz.com. .